FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037916291> ?p ?o ?g. }

• W3037916291 abstract "Summary Background The corona virus disease 2019 (COVID-19) pandemic poses a severe challenge to public health, especially to those patients with underlying diseases. In this meta-analysis, we studied the prevalence of cancer among patients with COVID-19 infection and their risks of severe events. Methods We searched the Pubmed, Embase and MedRxiv databases for studies between December 2019 and May 3, 2020 using the following key words and terms: sars-cov-2, covid-19, 2019-ncov, 2019 novel coronavirus, corona virus disease-2019, clinical, clinical characteristics, clinical course, epidemiologic features, epidemiology, and epidemiological characteristics. We extracted data following PICO (patient, intervention, comparison and outcome) chart. Statistical analyses were performed with R Studio (version 3.5.1) on the group-level data. We assessed the studies’ risk of bias in accordance to the adjusted Joanna Briggs Institute. We estimated the prevalence or risks for severe events including admission into intensive care unit or death using meta-analysis with random effects. Findings Out of the 2,551 studies identified, 32 studies comprising 21,248 participants have confirmed COVID-19. The total prevalence of cancer in COVID-19 patients was 3.97% (95% CI, 3.08% to 5.12%), higher than that of the total cancer rate (0.29%) in China. Stratification analysis showed that the overall cancer prevalence of COVID-19 patients in China was 2.59% (95% CI, 1.72% to 3.90%), and the prevalence reached 3.79% in Wuhan (95% CI, 2.51% to 5.70%) and 2.31% (95% CI, 1.16% to 4.57%) in other areas outside Wuhan in China. The incidence of ICU admission in cancer patients with COVID-19 was 26.80% (95% CI, 21.65% to 32.67%) and the mortality was 24.32% (95% CI, 13.95% to 38.91%), much higher than the overall rates of COVID-19 patients in China. The fatality in COVID patients with cancer was lower than those with cardiovascular disease (OR 0.49; 95% CI, 0.34 to 0.71; p=0.39), but comparable with other comorbidities such as diabetes (OR 1.32; 95% CI, 0.42 to 4.11; p=0.19), hypertension (OR 1.27; 95% CI, 0.35 to 4.62; p=0.13), and respiratory diseases (OR 0.79; 95% CI, 0.47 to 1.33; p=0.45). Interpretation This comprehensive meta-analysis on the largest number of patients to date provides solid evidence that COVID-19 infection significantly and negatively affected the disease course and prognosis of cancer patients. Awareness of this could help guide clinicians and health policy makers in combating cancer in the context of COVID-19 pandemic. Funding Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education (KZ202010025047)." @default.
• W3037916291 created "2020-07-02" @default.
• W3037916291 creator A5027572690 @default.
• W3037916291 creator A5029547026 @default.
• W3037916291 creator A5036405065 @default.
• W3037916291 creator A5057948519 @default.
• W3037916291 creator A5058950492 @default.
• W3037916291 creator A5064116412 @default.
• W3037916291 creator A5066507571 @default.
• W3037916291 creator A5088888083 @default.
• W3037916291 creator A5089843079 @default.
• W3037916291 date "2020-06-24" @default.
• W3037916291 modified "2023-10-18" @default.
• W3037916291 title "Prevalence and risks of severe events for cancer patients with COVID-19 infection: a systematic review and meta-analysis" @default.
• W3037916291 cites W2121135500 @default.
• W3037916291 cites W2440211190 @default.
• W3037916291 cites W2735586502 @default.
• W3037916291 cites W2981596557 @default.
• W3037916291 cites W2999417355 @default.
• W3037916291 cites W3006355661 @default.
• W3037916291 cites W3006485704 @default.
• W3037916291 cites W3007114958 @default.
• W3037916291 cites W3007273493 @default.
• W3037916291 cites W3007496130 @default.
• W3037916291 cites W3007814559 @default.
• W3037916291 cites W3008090866 @default.
• W3037916291 cites W3008207212 @default.
• W3037916291 cites W3008568763 @default.
• W3037916291 cites W3008827533 @default.
• W3037916291 cites W3009826263 @default.
• W3037916291 cites W3009885589 @default.
• W3037916291 cites W3009912996 @default.
• W3037916291 cites W3010538497 @default.
• W3037916291 cites W3011292867 @default.
• W3037916291 cites W3011508332 @default.
• W3037916291 cites W3011610993 @default.
• W3037916291 cites W3012690941 @default.
• W3037916291 cites W3012849736 @default.
• W3037916291 cites W3012860910 @default.
• W3037916291 cites W3013233995 @default.
• W3037916291 cites W3014677718 @default.
• W3037916291 cites W3014919143 @default.
• W3037916291 cites W3015552915 @default.
• W3037916291 cites W3015599879 @default.
• W3037916291 cites W3015671971 @default.
• W3037916291 cites W3016080263 @default.
• W3037916291 cites W3016139533 @default.
• W3037916291 cites W3016783119 @default.
• W3037916291 cites W3017792836 @default.
• W3037916291 cites W3018002710 @default.
• W3037916291 cites W3020177603 @default.
• W3037916291 cites W3023616880 @default.
• W3037916291 cites W3024193040 @default.
• W3037916291 cites W3025381259 @default.
• W3037916291 cites W3165656738 @default.
• W3037916291 cites W4294215472 @default.
• W3037916291 doi "https://doi.org/10.1101/2020.06.23.20136200" @default.
• W3037916291 hasPublicationYear "2020" @default.
• W3037916291 type Work @default.
• W3037916291 sameAs 3037916291 @default.
• W3037916291 citedByCount "2" @default.
• W3037916291 countsByYear W30379162912021 @default.
• W3037916291 crossrefType "posted-content" @default.
• W3037916291 hasAuthorship W3037916291A5027572690 @default.
• W3037916291 hasAuthorship W3037916291A5029547026 @default.
• W3037916291 hasAuthorship W3037916291A5036405065 @default.
• W3037916291 hasAuthorship W3037916291A5057948519 @default.
• W3037916291 hasAuthorship W3037916291A5058950492 @default.
• W3037916291 hasAuthorship W3037916291A5064116412 @default.
• W3037916291 hasAuthorship W3037916291A5066507571 @default.
• W3037916291 hasAuthorship W3037916291A5088888083 @default.
• W3037916291 hasAuthorship W3037916291A5089843079 @default.
• W3037916291 hasBestOaLocation W30379162911 @default.
• W3037916291 hasConcept C107130276 @default.
• W3037916291 hasConcept C121608353 @default.
• W3037916291 hasConcept C126322002 @default.
• W3037916291 hasConcept C2779134260 @default.
• W3037916291 hasConcept C3008058167 @default.
• W3037916291 hasConcept C524204448 @default.
• W3037916291 hasConcept C71924100 @default.
• W3037916291 hasConcept C89623803 @default.
• W3037916291 hasConcept C95190672 @default.
• W3037916291 hasConceptScore W3037916291C107130276 @default.
• W3037916291 hasConceptScore W3037916291C121608353 @default.
• W3037916291 hasConceptScore W3037916291C126322002 @default.
• W3037916291 hasConceptScore W3037916291C2779134260 @default.
• W3037916291 hasConceptScore W3037916291C3008058167 @default.
• W3037916291 hasConceptScore W3037916291C524204448 @default.
• W3037916291 hasConceptScore W3037916291C71924100 @default.
• W3037916291 hasConceptScore W3037916291C89623803 @default.
• W3037916291 hasConceptScore W3037916291C95190672 @default.
• W3037916291 hasLocation W30379162911 @default.
• W3037916291 hasOpenAccess W3037916291 @default.
• W3037916291 hasPrimaryLocation W30379162911 @default.
• W3037916291 hasRelatedWork W3103289217 @default.
• W3037916291 hasRelatedWork W3106370311 @default.
• W3037916291 hasRelatedWork W3119540162 @default.
• W3037916291 hasRelatedWork W3120887007 @default.
• W3037916291 hasRelatedWork W3152606407 @default.
• W3037916291 hasRelatedWork W3152916563 @default.

• next